Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With Fever

Study the Clinical and Laboratory Characteristics and the Outcome of Sickle Cell Anemia Patients Admitted to the Pediatric Ward Because of Fever as the Presenting Symptom

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00736060

Enrollment

Registered

2008-08-15

Start date

2008-05-31

Completion date

2008-11-30

Last updated

2011-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sickle Cell Anemia, Sickle Cell Thalassemia

Keywords

Fever, Blood cultures

Brief summary

This study will summarized the clinical and laboratory data and the outcome of all the patients suffering from Sickle Cell Anemia (Including Sickle cell thalassemia) admitted to the pediatric ward.

Detailed description

The actual protocol for SCA patients admitted with fever is to obtain blood cultures and start empiric antibiotic treatment. The study cohort included 60 SCA patients actually treated in the Pediatric Hematology Unit.

Interventions

OTHERObservational

Summary of clinical and laboratory data

Study design

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

All patients admitted with fever as the only presenting symptom.

Exclusion criteria

Patients admitted with another causes related or unrelated to sickle cell disease and have also fever.

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026